Clinical Trial Update: Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fixed-dose combination of brimonidine tartrate and ketotifen fumarate for seasonal allergic conjunctivitis has completed. Results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Conjunctivitis

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)
• Ketotifen Fumarate (ketotifen fumarate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Seasonal Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2025-07-01